However, the CD4+/CD8+ cell ratio was maintained in all tumor specimens (Fig. 2D) with the percentage of CD4+ cells maintained in 5 of 8 tumors (Fig. 2E and S5E) and the percentage of CD8+ cells maintained in 7 of 8 tumors (Fig. 2F and S5F). This evidence concerns the gene CD8A and neoplasm.